PTC Therapeutics, Inc.
PTCT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $15.63M | $6.77M | $1.68M | $6.85M |
| Net Income | -$38.91M | -$38.36M | -$25.10M | -$14.59M |
| EPS Diluted | -$1.14 |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.14 |
| -$0.86 |
| -$5.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.